US › Healthcare

VivoSim Labs, Inc. (VIVS)

US · Healthcare · Biotechnology

$0.16-5.88%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$18,000

Revenue YoY

-51.4%

Net profit

$-1.3M

EPS

$-0.25

Net margin

-7,433.3%

Key statistics

Market cap

$2.9M

Forward P/E

0.0

P/B

0.54

Book value

$-0.73

EPS (TTM)

$-4.47

52-week high

$3.40

52-week low

$0.16

50-day MA

$0.27

200-day MA

$1.20

Beta

1.49

Shareholding

Insiders

2.67%

Institutions

11.09%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.16%
Renaissance Technologies Corp	0.11%
HRT FINANCIAL LLC	0.11%
Vanguard Capital Management, LLC	0.09%
BlackRock Inc	0.07%
Vanguard Fiduciary Trust Co	0.04%
Tower Research Capital LLC	0.03%
SBI Securities Co Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for VivoSim Labs, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.